These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24088786)

  • 1. Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity.
    Huang JW; Wang Y; Dhillon KK; Calses P; Villegas E; Mitchell PS; Tewari M; Kemp CJ; Taniguchi T
    Mol Cancer Res; 2013 Dec; 11(12):1564-73. PubMed ID: 24088786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of miRNA modulators to PARP inhibitor response.
    Neijenhuis S; Bajrami I; Miller R; Lord CJ; Ashworth A
    DNA Repair (Amst); 2013 Jun; 12(6):394-402. PubMed ID: 23570906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
    Liu G; Yang D; Rupaimoole R; Pecot CV; Sun Y; Mangala LS; Li X; Ji P; Cogdell D; Hu L; Wang Y; Rodriguez-Aguayo C; Lopez-Berestein G; Shmulevich I; De Cecco L; Chen K; Mezzanzanica D; Xue F; Sood AK; Zhang W
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25995442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitin-specific peptidase 11 (USP11) as a regulator of DNA double-strand break repair.
    Wiltshire TD; Lovejoy CA; Wang T; Xia F; O'Connor MJ; Cortez D
    J Biol Chem; 2010 May; 285(19):14565-71. PubMed ID: 20233726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of impaired homologous recombination repair in NSCLC cells and tissues.
    Birkelbach M; Ferraiolo N; Gheorghiu L; Pfäffle HN; Daly B; Ebright MI; Spencer C; O'Hara C; Whetstine JR; Benes CH; Sequist LV; Zou L; Dahm-Daphi J; Kachnic LA; Willers H
    J Thorac Oncol; 2013 Mar; 8(3):279-86. PubMed ID: 23399959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-34s negatively regulate homologous recombination through targeting RAD51.
    Chen S; Liu R; Wang Q; Qi Z; Hu Y; Zhou P; Wang Z
    Arch Biochem Biophys; 2019 May; 666():73-82. PubMed ID: 30951682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs down-regulate homologous recombination in the G1 phase of cycling cells to maintain genomic stability.
    Choi YE; Pan Y; Park E; Konstantinopoulos P; De S; D'Andrea A; Chowdhury D
    Elife; 2014 Apr; 3():e02445. PubMed ID: 24843000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC.
    Sun C; Cao W; Qiu C; Li C; Dongol S; Zhang Z; Dong R; Song K; Yang X; Zhang Q; Kong B
    J Hematol Oncol; 2020 Jan; 13(1):9. PubMed ID: 32005272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BET proteins regulate homologous recombination-mediated DNA repair: BRCAness and implications for cancer therapy.
    Mio C; Gerratana L; Bolis M; Caponnetto F; Zanello A; Barbina M; Di Loreto C; Garattini E; Damante G; Puglisi F
    Int J Cancer; 2019 Feb; 144(4):755-766. PubMed ID: 30259975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of FGFR2-Signaling Attenuates a Homology-Mediated DNA Repair in GIST and Sensitizes Them to DNA-Topoisomerase II Inhibitors.
    Sergei B; Pavel D; Aigul G; Firyuza B; Ilmira N; Ilshat M; Aida A; Refat K; Natalia A; Elena S; Vera G
    Int J Mol Sci; 2020 Jan; 21(1):. PubMed ID: 31948066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel UCHL
    Song Z; Tu X; Zhou Q; Huang J; Chen Y; Liu J; Lee S; Kim W; Nowsheen S; Luo K; Yuan J; Lou Z
    Cell Death Dis; 2019 May; 10(6):398. PubMed ID: 31113933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.
    Wang Y; Huang JW; Calses P; Kemp CJ; Taniguchi T
    Cancer Res; 2012 Aug; 72(16):4037-46. PubMed ID: 22761336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTCF prevents genomic instability by promoting homologous recombination-directed DNA double-strand break repair.
    Lang F; Li X; Zheng W; Li Z; Lu D; Chen G; Gong D; Yang L; Fu J; Shi P; Zhou J
    Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10912-10917. PubMed ID: 28973861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression.
    Wang Y; Huang JW; Li M; Cavenee WK; Mitchell PS; Zhou X; Tewari M; Furnari FB; Taniguchi T
    Mol Cancer Res; 2011 Aug; 9(8):1100-11. PubMed ID: 21693595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion of homology-directed DNA repair by polyamines.
    Lee CY; Su GC; Huang WY; Ko MY; Yeh HY; Chang GD; Lin SJ; Chi P
    Nat Commun; 2019 Jan; 10(1):65. PubMed ID: 30622262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA lnc-RI regulates homologous recombination repair of DNA double-strand breaks by stabilizing RAD51 mRNA as a competitive endogenous RNA.
    Shen L; Wang Q; Liu R; Chen Z; Zhang X; Zhou P; Wang Z
    Nucleic Acids Res; 2018 Jan; 46(2):717-729. PubMed ID: 29216366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-mediated inhibition of RAD51 expression and homologous recombination in cancer cells.
    Du LQ; Du XQ; Bai JQ; Wang Y; Yang QS; Wang XC; Zhao P; Wang H; Liu Q; Fan FY
    J Cancer Res Clin Oncol; 2012 May; 138(5):811-8. PubMed ID: 22274865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC Inhibition Induces MicroRNA-182, which Targets RAD51 and Impairs HR Repair to Sensitize Cells to Sapacitabine in Acute Myelogenous Leukemia.
    Lai TH; Ewald B; Zecevic A; Liu C; Sulda M; Papaioannou D; Garzon R; Blachly JS; Plunkett W; Sampath D
    Clin Cancer Res; 2016 Jul; 22(14):3537-49. PubMed ID: 26858310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRIP1 cooperates with BRCA2 to drive the nuclear enrichment of RAD51 and to facilitate homologous repair upon DNA damage induced by chemotherapy.
    Sun H; Zhou R; Zheng Y; Wen Z; Zhang D; Zeng D; Wu J; Huang Z; Rong X; Huang N; Sun L; Bin J; Liao Y; Shi M; Liao W
    Oncogene; 2021 Aug; 40(34):5342-5355. PubMed ID: 34262130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic loss of prostate cancer cell viability by coinhibition of HDAC and PARP.
    Chao OS; Goodman OB
    Mol Cancer Res; 2014 Dec; 12(12):1755-66. PubMed ID: 25127709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.